The 90-Day Repricing Event: Anthropic's S-1 Forces Every AI Mark Into the Light
What Just Happened
Anthropic filed a confidential S-1 targeting fall 2026 at a valuation between $900B and $965B on an annualized revenue run-rate of $47B, up from roughly nine billion six months ago. A 5.2x jump in half a year is either the fastest legitimate revenue ramp in software history or a reminder that six-month-old enterprise contracts make ARR a number doing considerable work. Probably both.
The filing landed the same week OpenAI is reportedly preparing its own roughly one-trillion-dollar registration, which creates a dual-IPO window asking public markets to absorb more than fifty billion in primary from two frontier labs in the same quarter. That level of supply has no modern precedent.
Why This Changes Your Book
Until this filing, every late-stage AI mark lived in a fog of private-round comps set by strategically motivated counterparties. Once Anthropic prints, the fog lifts. The implied multiple — roughly 20x forward revenue at 5x growth — becomes the ceiling rather than the floor for every private AI name in the pipeline.
Any private AI company pitching 50-100x ARR is now mispriced relative to a public comp that just emerged. The next 90 days are the window to remark before auditors do it for you.
The OpenAI Spread Trade
Florida's 83-page product-liability suit naming Altman personally, citing the FSU shooter's 270+ ChatGPT messages and two USF student deaths, opens a measurable gap between the two leaders at precisely the wrong moment for OpenAI's roadshow. Sources diverge on the sizing — estimates run from fifteen to twenty-five percent discount warranted for OpenAI versus Anthropic on secondaries. Bill Gurley publicly calling Anthropic a 'mystery' and invoking 'Dr. Frankenstein' is a tier-one VC distancing weeks before an IPO. That is governance risk the public narrative has not priced.
Three Scenarios to Model
| Scenario | Probability | Portfolio Impact |
|---|---|---|
| Prices at/above $965B, trades well | 40% | Late-stage AI marks re-rate upward; 4-6 week secondary pull-through |
| Prices at target, trades poorly | 35% | Most informative outcome — tells you what next 12 months look like |
| Prices below or deal pulled | 25% | Quiet markdowns ripple through 2024-2025 vintage; IPO window closes |
Cross-Source Contradictions Worth Noting
Sources disagree on whether $47B is gross or net revenue. One read has Anthropic's figure pre-inference-partner payments while OpenAI's $30B is net, meaning the headline gap overstates Anthropic's lead. The S-1 treatment of compute costs will resolve it, but the distinction matters for multiple derivation. Opus 4.8's split benchmarks — ARC-AGI-3 shows it tripling GPT-5.5, while Datacurve shows it below GPT-5.5 with higher token burn — leave open whether 20x revenue is paid for product differentiation or, more plausibly, the growth rate alone.
What to do
Reprice every late-stage AI position against ~20x forward revenue; flag any mark above 40x for IC review this week
Source pre-IPO Anthropic secondaries below the $965B mark with IPO ratchet protection before tertiary markets tighten
Build three-scenario LP communication for fall: above-$965B, at-target, and pulled/discounted — circulate before Q3 statements
Open paired-trade view: long Anthropic secondaries, underweight OpenAI tender at parity until Florida litigation path clarifies